-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Albireo Pharma (ALBO), "We Remain Highly Confident in Bylvay's Likelihood of Success"
-
-
-
-
-
-
-
Albireo Pharma (ALBO) PT Raised to $76 at H.C. Wainwright, Following Clinical Business Update
-
-
-
-
-
-
-
Albireo to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Albireo to Present at H.C. Wainwright Global Life Sciences Conference
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

